Nanofiltration vs. reverse osmosis for the removal of emerging organic contaminants in water reuse

Desalination and Water Treatment

Volumn 34, Issue 1-3, 2011, Pages 50-56

  Yangali Quintanilla, Victor ^a,b   Maeng, Sung Kyu ^a,c   Fujioka, Takahiro ^a   Kennedy, Maria ^a   Li, Zhenyu ^b   Amy, Gary ^a,b  

^a UNESCO IHE INSTITUTE FOR WATER EDUCATION   (Netherlands)

^b KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Emerging contaminants; Nanofiltration; Reverse osmosis; Water reuse

Indexed keywords

EID: 80054883350     PISSN: 19443994     EISSN: 19443986     Source Type: Journal    
DOI: 10.5004/dwt.2011.2860     Document Type: Article

References (41)

1. Majamaa, K., Aerts, P. E. M., Groot, C., Paping, L. L. M. J., Van den Broek, W., and Van Agtmaal, S., 2010. Industrial water reuse with integrated membrane system increases the sustainability of the chemical manufacturing. Desalin. Water Treat.,:17–23.
2. Abusam, A., and Shahalam, A., 2010. Comparative assesment of advanced membrane treatment of municipal wastewater for reuse in Kuwait. Desalin. Water Treat.,:254–258.
3. Brammer, T., Staib, C., Susarla, P., and Rohe, D., 2010. Drought relief by water reuse in Queensland, Australia:The Murrumba Downs advanced water treatment plant. AMTA 2010 Annual Conference and Exposition. July12–152010, San Diego.
4. Freeman, B. R., Peck, S., Drossos, N., Kawashima, T., Franks, R., Itonaga, T., and Oda, Y., 2010. Advancing the use of integrated membrane bioreactor reverse osmosis technology to reclaim wastewater thru pilot testing. AMTA 2010 Annual Conference and Exposition. July12–152010, San Diego.
5. Martin, C., 2010. Water reuse market helps Spain secure future supply
6. Ortega, E., and Iglesias, R., 2009. Reuse of treated municipal wastewater effluents in Spain Regulations and most common technologies, including extensive treatments. Desalin. Water Treat.,:148–160.
7. Snyder, S. A., Westerhoff, P., Yoon, Y., and Sedlak, D. L., 2003. Pharmaceuticals, personal care products, and endocrine disruptors in water:Implications for the water industry. Environ. Eng. Sc., 5:449–469.
8. Vieno, N., Tuhkanen, T., and Kronberg, L., 2006. Removal of pharmaceuticals in drinking water treatment:Effect of chemical coagulation. Environ. Technol., 2:183–192.
9. Zorita, S., Mårtensson, L., and Mathiasson, L., 2009. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Science of The Total Environment, 8:2760–2770.
10. Verliefde, A., Cornelissen, E., Amy, G., Van der Bruggen, B., and van Dijk, H., 2007. Priority organic micropollutants in water sources in Flanders and the Netherlands and assessment of removal possibilities with nanofiltration. Environ. Pollut., 1:281–289.
11. Peng, X., Yu, Y., Tang, C., Tan, J., Huang, Q., and Wang, Z., 2008. Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Science of The Total Environment, 1–3:158–166.
12. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D., and Snyder, S. A., 2008. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ. Sci. Technol., 3:597–603.
13. Van der Bruggen, B., Schaep, J., Wilms, D., and Vandecasteele, C., 1999. Influence of molecular size, polarity and charge on the retention of organic molecules by nanofiltration. J. Membr. Sci., 1:29–41.
14. Kiso, Y., Sugiura, Y., Kitao, T., and Nishimura, K., 2001. Effects of hydrophobicity and molecular size on rejection of aromatic pesticides with nanofiltration membranes. J. Membr. Sci., 1–2:1–10.
15. Ozaki, H., and Li, H., 2002. Rejection of organic compounds by ultra-low pressure reverse osmosis membrane. Water Res., 1:123–130.
16. Schafer, A. I., Nghiem, L. D., and Waite, T. D., 2003. Removal of the natural hormone estrone from aqueous solutions using nanofiltration and reverse osmosis. Environ. Sci. Technol., 1:182–188.
17. Kimura, K., Toshima, S., Amy, G., and Watanabe, Y., 2004. Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J. Membr. Sci., 1–2:7–78.
18. Nghiem, L. D., Schafer, A. I., and Elimelech, M., 2004. Removal of natural hormones by nanofiltration membranes:Measurement, modeling, and mechanisms. Environ. Sci. Technol., 6:1888–1896.
19. Radjenovic, J., Petrovic, M., Ventura, F., and Barceló, D., 2008. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res., 14:3601–3610.
20. Bellona, C., Drewes, J. E., Oelker, G., Luna, J., Filteau, G., and Amy, G., 2008. Comparing nanofiltration and reverse osmosis for drinking water augmentation. Journal American Water Works Association, 9:102–116.
21. Schrotter, J.-C., Breda, C., Vince, F., De Roubin, M.-R., Roche, P., and Bréant, P., 2009. TECHNEAU:Safe drinking water from source to tap, state of the art & pespectives, Edited by:Van den Hoven, T., and Kazner, C., London, UK:IWA Publishing.
22. Santos, J. L. C., de Beukelaar, P., Vankelecom, I. F. J., Velizarov, S., and Crespo, J. G., 2006. Effect of solute geometry and orientation on the rejection of uncharged compounds by nanofiltration. Sep. Purif. Technol., 1:122–131.
23. Sacher, F., Ehmann, M., Gabriel, S., Graf, C., and Brauch, H. J., 2008. Pharmaceutical residues in the river Rhine - results of a one-decade monitoring programme. J. Environ. Monit., 5:664–670.
24. Sacher, F., Lange, F. T., Brauch, H. J., and Blankenhorn, I., 2001. Pharmaceuticals in groundwaters analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany. J. Chromatogr. A., 1–2:199–210.
25. Schlett, C., and Pfeifer, B., 1996. Bestimmung von Steroidhormonen in Trink-und Oberflächenwässer = Determination of steroidal in drinking and surface water samples, 327–333. Vom Wasser.
26. Yangali-Quintanilla, V., Sadmani, A., Kennedy, M., and Amy, G., 2010. A QSAR (quantitative structure-activity relationship) approach for modellingand prediction of rejection of emerging contaminants by NF membranes. Desalin. Water Treat.,:149–155.
27. Yangali-Quintanilla, V., Sadmani, A., McConville, M., Kennedy, M., and Amy, G., 2009. Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes. Water Res., 9:2349–2362.
28. Maeng, S. K., Sharma, S. K., Amy, G., and Magic-Knezev, A., 2008. Fate of effluent organic matter (EfOM) and natural organic matter (NOM) through riverbank filtration. Water Sci. Technol., 12:1999–2007.
29. Verliefde, A. R. D., Cornelissen, E. R., Heijman, S. G. J., Verberk, J. Q. J. C., Amy, G. L., Van der Bruggen, B., and van Dijk, J. C., 2009. Construction and validation of a full-scale model for rejection of organic micropollutants by NF membranes. J. Membr. Sci., 1–2:10–20.
30. Kiso, Y., Nishimura, Y., Kitao, T., and Nishimura, K., 2000. Rejection properties of non-phenylic pesticides with nanofiltration membranes. J. Membr. Sci., 2:229-237
31. Kiso, Y., Kon, T., Kitao, T., and Nishimura, K., 2001. Rejection properties of alkyl phthalates with nanofiltration membranes. J. Membr. Sci., 1–2:205–214.
32. Kimura, K., Amy, G., Drewes, J., and Watanabe, Y., 2003. Adsorption of hydrophobic compounds onto NF/RO membranes:an artifact leading to overestimation of rejection. J. Membr. Sci., 1–2:89–101.
33. Kimura, K., Amy, G., Drewes, J. E., Heberer, T., Kim, T. U., and Watanabe, Y., 2003. Rejection of organic micropollutants (disinfection by-products, endocrine disrupting compounds, and pharmaceutically active compounds) by NF/RO membranes. J. Membr. Sci., 1–2:113–121.
34. Chen, S-. S., Taylor, J. S., Mulford, L. A., and Norris, C. D., 2004. Influences of molecular weight, molecular size, flux, and recovery for aromatic pesticide removal by nanofiltration membranes. Desalination, 2:103-111
35. Bellona, C., Drewes, J. E., Xu, P., and Amy, G., 2004. Factors affecting the rejection of organic solutes during NF/RO treatment - a literature review. Water Res., 12:2795–2809.
36. Kiso, Y., Kitao, T., Jinno, K., and Miyagi, M., 1992. The Effects of Molecular Width on Permeation of Organic Solute through Cellulose-Acetate Reverse-Osmosis Membranes. J. Membr. Sci., 1–2:95–103.
37. Van der Bruggen, B., Schaep, J., Wilms, D., and Vandecasteele, C., 2000. A comparison of models to describe the maximal retention of organic molecules in nanofiltration. Sep. Sci. Technol., 2:169–182.
38. Yangali-Quintanilla, V., Verliefde, A., Kim, T. U., Sadmani, A., Kennedy, M., and Amy, G., 2009. Artificial neural network models based on QSAR for predicting rejection of neutral organic compounds by polyamide nanofiltration and reverse osmosis membranes. J. Membr. Sci., 1–2:251–262.
39. Yoon, Y., Westerhoff, P., Snyder, S. A., and Wert, E. C., 2006. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Membr. Sci., 1–2:88–100.
40. Bellona, C., and Drewes, J. E., 2005. The role of membrane surface charge and solute physico-chemical properties in the rejection of organic acids by NF membranes. J. Membr. Sci., 1–2:227–234.
41. Nghiem, L. D., Schafer, A. I., and Elimelech, M., 2006. Role of electrostatic interactions in the retention of pharmaceutically active contaminants by a loose nanofiltration membrane. J. Membr. Sci., 1–2:52–59.